Clinical Trial: A Long-term Safety Study of Olumacostat Glasaretil Gel in Subjects With Acne Vulgaris

Study Status: Recruiting
Recruit Status: Recruiting
Study Type: Interventional

Official Title: An Open-Label Study Assessing Long-Term Safety of Olumacostat Glasaretil Gel in Subjects With Acne Vulgaris

Brief Summary: The objectives of this study are to assess the long-term safety of Olumacostat Glasaretil gel, 5.0% in patients with acne vulgaris

Detailed Summary:
Sponsor: Dermira, Inc.

Current Primary Outcome: Safety assessed by adverse events (AEs) [ Time Frame: Up to 36 weeks ]

Safety assessed by adverse events (AEs)


Original Primary Outcome: Same as current

Current Secondary Outcome:

Original Secondary Outcome:

Information By: Dermira, Inc.

Dates:
Date Received: April 17, 2017
Date Started: March 21, 2017
Date Completion: March 2019
Last Updated: April 20, 2017
Last Verified: March 2017